CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

Our results demonstrate that CAR-CIK cells are at least equipotent to CAR-T cells. Combined with their favorable safety profile and allogeneic applicability, these findings position CAR-CIK cells as promising immune effectors for solid tumors.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-02-03
DOI
https://doi.org/10.3389/fimmu.2025.1485817
Citations
8
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
8.36

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

Christian Münch, Hermann Kreyenberg, Sabine Harenkamp, Evelyn Ullrich et al.
8 citations
Frontiers in Immunology
CAR-T cell therapy research
8.36
article

CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma

Christian Münch, Hermann Kreyenberg, Sabine Harenkamp, Evelyn Ullrich, Peter Bader, Jan‐Henning Klusmann, Catrin Heim, Winfried S. Wels, Elise Gradhand, Eva Rettinger, Philipp Wendel, Sebastian E. Koschade, Halvard Bönig, Laura M. Moser, Meike Vogler, Süleyman Bozkurt, Michael Merker
article en
8 citations

Abstract

Our results demonstrate that CAR-CIK cells are at least equipotent to CAR-T cells. Combined with their favorable safety profile and allogeneic applicability, these findings position CAR-CIK cells as promising immune effectors for solid tumors.

Frontiers in ImmunologyVol. 16
Goethe University Frankfurt (DE), University of Washington (US), Technische Universität Darmstadt (DE), Institute of Clinical Cancer Research (DE), Georg Speyer Haus (DE), Cardio-Pulmonary Institute (DE), Frankfurt Cancer Institute (DE), Deutsches Konsortium für Translationale Krebsforschung (DE)
Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung, Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung für Krebsforschung, Deutsche Kinderkrebsstiftung
Good health and well-being
Openalex Percentile: Top 2%
CAR-T cell therapy research
8.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.